UTMD – Utah Medical Products, Inc.

Float Short %

3.43

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

57.49

Target Price

65.23

Analyst Recom

Performance Q

-8.02

Relative Volume

1.24

Beta

0.33

Ticker: UTMD

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-17	UTMD	55.35	N/A	N/A	0
2025-11-18	UTMD	54.55	N/A	N/A	0
2025-11-19	UTMD	54.63	N/A	N/A	0
2025-11-20	UTMD	53.89	N/A	N/A	0
2025-11-21	UTMD	55.13	N/A	N/A	0
2025-11-24	UTMD	55.32	N/A	N/A	0
2025-11-25	UTMD	55.49	N/A	N/A	0
2025-11-26	UTMD	55.8	N/A	N/A	0
2025-12-01	UTMD	55.22	N/A	N/A	0
2025-12-02	UTMD	55.53	N/A	N/A	0
2025-12-03	UTMD	55.39	N/A	N/A	0
2025-12-04	UTMD	55.99	N/A	N/A	0
2025-12-05	UTMD	56.03	N/A	N/A	0
2025-12-08	UTMD	55.5	N/A	N/A	0
2025-12-09	UTMD	55.78	N/A	N/A	0
2025-12-10	UTMD	56.34	N/A	N/A	0
2025-12-11	UTMD	57.5	N/A	N/A	0
2025-12-12	UTMD	58.21	N/A	N/A	0
2025-12-15	UTMD	57.64	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-17	UTMD	55.01	-	-	-
2025-11-18	UTMD	54.66	-	-	-
2025-11-19	UTMD	53.90	-	-	-
2025-11-20	UTMD	53.87	-	-	-
2025-11-21	UTMD	54.94	-	-	-
2025-11-24	UTMD	54.80	-	-	-
2025-11-25	UTMD	55.93	-	-	-
2025-11-26	UTMD	55.87	-	-	-
2025-12-01	UTMD	55.16	-	-	-
2025-12-02	UTMD	54.88	-	-	-
2025-12-03	UTMD	55.63	-	-	-
2025-12-04	UTMD	55.96	-	-	-
2025-12-05	UTMD	56.01	-	-	-
2025-12-08	UTMD	55.52	-	-	-
2025-12-09	UTMD	55.65	-	-	-
2025-12-10	UTMD	56.57	-	-	-
2025-12-11	UTMD	57.50	-	-	-
2025-12-12	UTMD	58.03	-	-	-
2025-12-15	UTMD	57.49	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-17	UTMD	0.00	0.79	3.55
2025-11-18	UTMD	0.00	0.79	3.55
2025-11-19	UTMD	0.00	0.79	3.55
2025-11-20	UTMD	0.00	0.79	3.55
2025-11-21	UTMD	0.00	0.79	3.55
2025-11-24	UTMD	0.00	0.73	3.55
2025-11-25	UTMD	0.00	0.73	3.55
2025-11-26	UTMD	0.00	0.73	3.45
2025-12-01	UTMD	0.00	1.16	3.45
2025-12-02	UTMD	0.00	1.16	3.45
2025-12-03	UTMD	0.00	1.16	3.45
2025-12-04	UTMD	0.00	1.16	3.45
2025-12-05	UTMD	0.00	1.16	3.45
2025-12-08	UTMD	0.00	1.14	3.45
2025-12-09	UTMD	0.00	1.14	3.45
2025-12-10	UTMD	0.00	1.14	3.41
2025-12-11	UTMD	0.00	1.14	3.41
2025-12-12	UTMD	0.00	1.14	3.41
2025-12-15	UTMD	0.00	1.43	3.43
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="UTMD" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

1.43

Beta

0.33

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

67.22

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

57.1

Max Drawdown 5-Year %

-55.6

Target Price

65.23

P/E

16.26

Forward P/E

PEG

P/S

4.77

P/B

1.56

P/Free Cash Flow

13.27

EPS

3.53

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

30.08

Relative Volume

1.24

Return on Equity vs Sector %

-17.2

Return on Equity vs Industry %

-0.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”UTMD” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTMD” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTMD” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTMD” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTMD” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTMD” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTMD” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Utah Medical Products, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 155

Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. The company serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

stock quote shares UTMD – Utah Medical Products, Inc. Stock Price stock today

news today UTMD – Utah Medical Products, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch UTMD – Utah Medical Products, Inc. yahoo finance google finance

stock history UTMD – Utah Medical Products, Inc. invest stock market

stock prices UTMD premarket after hours

ticker UTMD fair value insiders trading

ATRI – Atrion Corp.

Float Short %

2.53

Margin Of Safety %

-2

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

459.92

Target Price

300

Analyst Recom

Performance Q

-2.64

Relative Volume

Beta

0.69

Ticker: ATRI

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-17	ATRI	459.92	N/A	N/A	0
2025-11-18	ATRI	459.92	N/A	N/A	0
2025-11-19	ATRI	459.92	N/A	N/A	0
2025-11-20	ATRI	459.92	N/A	N/A	0
2025-11-21	ATRI	459.92	N/A	N/A	0
2025-11-24	ATRI	459.92	N/A	N/A	0
2025-11-25	ATRI	459.92	N/A	N/A	0
2025-11-26	ATRI	459.92	N/A	N/A	0
2025-12-01	ATRI	459.92	N/A	N/A	0
2025-12-02	ATRI	459.92	N/A	N/A	0
2025-12-03	ATRI	459.92	N/A	N/A	0
2025-12-04	ATRI	459.92	N/A	N/A	0
2025-12-05	ATRI	459.92	N/A	N/A	0
2025-12-08	ATRI	459.92	N/A	N/A	0
2025-12-09	ATRI	459.92	N/A	N/A	0
2025-12-10	ATRI	459.92	N/A	N/A	0
2025-12-11	ATRI	459.92	N/A	N/A	0
2025-12-12	ATRI	459.92	N/A	N/A	0
2025-12-15	ATRI	459.92	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ATRI" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

0.69

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

452.44

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

45.7

Max Drawdown 5-Year %

-66

Target Price

300

P/E

64.5

Forward P/E

PEG

P/S

4.46

P/B

3.39

P/Free Cash Flow

29.24

EPS

7.13

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.91

Relative Volume

Return on Equity vs Sector %

-18.1

Return on Equity vs Industry %

-3.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ATRI” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATRI” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATRI” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATRI” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATRI” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATRI” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATRI” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

stock quote shares ATRI – Atrion Corp. Stock Price stock today

news today ATRI – Atrion Corp. stock forecast ,stock prediction 2023 2024 2025

marketwatch ATRI – Atrion Corp. yahoo finance google finance

stock history ATRI – Atrion Corp. invest stock market

stock prices ATRI premarket after hours

ticker ATRI fair value insiders trading

ATR – Aptargroup Inc.

Float Short %

1.99

Margin Of Safety %

Put/Call OI Ratio

0.99

EPS Next Q Diff

-0.41

EPS Last/This Y

0.07

EPS This/Next Y

-0.11

Price

122.33

Target Price

161

Analyst Recom

1.7

Performance Q

-9.53

Relative Volume

1.05

Beta

0.49

Ticker: ATR

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-17	ATR	119.32	1.34	3.00	3473
2025-11-18	ATR	119.32	1.34	0.95	3470
2025-11-19	ATR	117.93	1.22	0.99	3615
2025-11-20	ATR	118.54	1.20	12.00	3711
2025-11-21	ATR	121.53	1.19	0.58	3698
2025-11-24	ATR	121.47	1.07	0.05	2283
2025-11-25	ATR	123.49	1.04	0.07	2321
2025-11-26	ATR	123.81	1.01	0.50	2350
2025-12-01	ATR	123.23	1.01	1.40	2351
2025-12-02	ATR	121.59	1.01	5.00	2357
2025-12-03	ATR	122.03	1.01	0.02	2356
2025-12-04	ATR	122.03	0.99	0.20	2375
2025-12-05	ATR	121.84	0.99	999.99	2379
2025-12-08	ATR	120.11	0.99	0.40	2379
2025-12-09	ATR	115.7	0.98	3.33	2379
2025-12-10	ATR	117.23	0.99	0.67	2392
2025-12-11	ATR	118.02	0.99	999.99	2391
2025-12-12	ATR	120.93	0.99	10.00	2392
2025-12-15	ATR	122.31	0.99	0.71	2392
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-17	ATR	119.35	-18.7	-62.3	5.71
2025-11-18	ATR	119.33	-18.7	-65.3	5.71
2025-11-19	ATR	118.00	-18.7	-70.0	5.71
2025-11-20	ATR	118.57	-18.7	-63.0	5.71
2025-11-21	ATR	121.50	-18.7	-54.2	5.71
2025-11-24	ATR	121.47	-18.7	-65.3	5.71
2025-11-25	ATR	123.44	-18.7	-57.9	5.71
2025-11-26	ATR	123.80	-18.7	-63.8	5.71
2025-12-01	ATR	123.30	-18.7	-70.3	5.71
2025-12-02	ATR	121.60	-18.7	-71.2	5.71
2025-12-03	ATR	122.06	-18.7	-63.4	5.71
2025-12-04	ATR	121.99	-18.7	-65.4	5.71
2025-12-05	ATR	121.91	-18.7	-65.5	5.71
2025-12-08	ATR	120.07	-18.7	-	5.71
2025-12-09	ATR	115.72	-18.7	-81.2	5.71
2025-12-10	ATR	115.72	-18.7	-59.5	5.71
2025-12-11	ATR	118.01	-18.7	-62.0	5.71
2025-12-12	ATR	121.44	-18.7	-52.3	5.71
2025-12-15	ATR	122.33	-18.7	-62.0	5.71
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-17	ATR	-3.91	2.87	1.74
2025-11-18	ATR	-3.91	2.87	1.74
2025-11-19	ATR	-3.91	2.87	1.74
2025-11-20	ATR	-3.41	2.87	1.74
2025-11-21	ATR	-3.41	2.87	1.74
2025-11-24	ATR	-1.56	-1.17	1.74
2025-11-25	ATR	-1.56	-1.17	1.74
2025-11-26	ATR	-1.56	-1.17	1.96
2025-12-01	ATR	-1.61	-1.17	1.96
2025-12-02	ATR	-1.61	-1.17	1.96
2025-12-03	ATR	-1.61	-1.17	1.96
2025-12-04	ATR	-1.61	-1.17	1.96
2025-12-05	ATR	-1.61	-1.17	1.96
2025-12-08	ATR	-1.61	-1.17	1.96
2025-12-09	ATR	-1.61	-1.17	1.96
2025-12-10	ATR	-1.12	-1.17	1.99
2025-12-11	ATR	-0.86	-1.17	1.99
2025-12-12	ATR	-0.86	-1.17	1.99
2025-12-15	ATR	-0.86	-1.13	1.99
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ATR" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

1.62

Avg. EPS Est. Current Quarter

1.24

Avg. EPS Est. Next Quarter

1.21

Insider Transactions

-0.86

Institutional Transactions

-1.13

Beta

0.49

Average Sales Estimate Current Quarter

880

Average Sales Estimate Next Quarter

933

Fair Value

133.39

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

31.3

Max Drawdown 5-Year %

-39.8

Target Price

161

P/E

19.6

Forward P/E

21.5

PEG

3.81

P/S

2.19

P/B

2.9

P/Free Cash Flow

25.49

EPS

6.24

Average EPS Est. Cur. Y

5.71

EPS Next Y. (Est.)

5.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.45

Relative Volume

1.05

Return on Equity vs Sector %

-11.9

Return on Equity vs Industry %

5.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

-62

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ATR” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATR” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATR” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATR” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATR” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATR” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ATR” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

AptarGroup, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 13500

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

stock quote shares ATR – Aptargroup Inc. Stock Price stock today

news today ATR – Aptargroup Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ATR – Aptargroup Inc. yahoo finance google finance

stock history ATR – Aptargroup Inc. invest stock market

stock prices ATR premarket after hours

ticker ATR fair value insiders trading

ANIK – Anika Therapeutics Inc.

Float Short %

3.2

Margin Of Safety %

-25

Put/Call OI Ratio

0.17

EPS Next Q Diff

0.17

EPS Last/This Y

-0.29

EPS This/Next Y

0.39

Price

9.57

Target Price

Analyst Recom

Performance Q

10.64

Relative Volume

1.28

Beta

0.46

Ticker: ANIK

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-17	ANIK	9.66	N/A	N/A	0
2025-11-18	ANIK	9.65	0.12	0.00	893
2025-11-19	ANIK	9.51	0.13	0.00	839
2025-11-20	ANIK	9.29	0.13	0.00	839
2025-11-21	ANIK	9.88	0.13	999.99	841
2025-11-24	ANIK	9.88	0.13	999.99	841
2025-11-25	ANIK	9.99	0.17	0.50	605
2025-11-26	ANIK	9.79	0.17	0.00	608
2025-12-01	ANIK	9.77	0.17	0.00	612
2025-12-02	ANIK	9.45	0.17	0.00	612
2025-12-03	ANIK	9.48	0.17	0.00	612
2025-12-04	ANIK	9.49	0.17	999.99	612
2025-12-05	ANIK	9.6	0.17	999.99	612
2025-12-08	ANIK	9.63	0.17	0.00	613
2025-12-09	ANIK	9.52	0.17	0.00	613
2025-12-10	ANIK	9.66	0.17	0.00	613
2025-12-11	ANIK	9.51	0.17	0.00	613
2025-12-12	ANIK	9.57	0.17	0.00	614
2025-12-15	ANIK	9.58	0.17	0.00	614
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-17	ANIK	9.64	166.7	-	-0.13
2025-11-18	ANIK	9.65	166.7	-	-0.13
2025-11-19	ANIK	9.52	166.7	-	-0.13
2025-11-20	ANIK	9.28	166.7	-	-0.13
2025-11-21	ANIK	9.87	166.7	-	-0.13
2025-11-24	ANIK	9.87	166.7	-	-0.13
2025-11-25	ANIK	9.98	166.7	-	-0.13
2025-11-26	ANIK	9.83	166.7	-	-0.13
2025-12-01	ANIK	9.76	166.7	-	-0.13
2025-12-02	ANIK	9.43	166.7	-	-0.13
2025-12-03	ANIK	9.47	166.7	-	-0.13
2025-12-04	ANIK	9.48	166.7	-	-0.13
2025-12-05	ANIK	9.60	166.7	-	-0.13
2025-12-08	ANIK	9.63	166.7	-	-0.13
2025-12-09	ANIK	9.52	166.7	-	-0.13
2025-12-10	ANIK	9.52	166.7	-	-0.13
2025-12-11	ANIK	9.49	166.7	-	-0.13
2025-12-12	ANIK	9.57	166.7	-	-0.13
2025-12-15	ANIK	9.57	166.7	-	-0.13
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-17	ANIK	0.00	5.89	2.24
2025-11-18	ANIK	0.00	5.89	2.24
2025-11-19	ANIK	0.00	5.89	2.24
2025-11-20	ANIK	0.00	5.89	2.24
2025-11-21	ANIK	0.00	5.89	2.24
2025-11-24	ANIK	0.00	-0.54	2.24
2025-11-25	ANIK	0.00	-0.54	2.24
2025-11-26	ANIK	0.00	-0.54	2.39
2025-12-01	ANIK	0.00	-0.56	2.39
2025-12-02	ANIK	0.00	-0.56	2.39
2025-12-03	ANIK	0.00	-0.56	2.39
2025-12-04	ANIK	0.00	-0.56	2.39
2025-12-05	ANIK	0.00	-0.56	2.39
2025-12-08	ANIK	0.00	-0.66	2.39
2025-12-09	ANIK	0.00	-0.66	2.39
2025-12-10	ANIK	0.00	-0.66	3.20
2025-12-11	ANIK	0.00	-0.66	3.20
2025-12-12	ANIK	0.00	-0.66	3.20
2025-12-15	ANIK	0.00	-0.70	3.20
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ANIK" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.17

Avg. EPS Est. Current Quarter

0.02

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.7

Beta

0.46

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

7.15

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

80.2

Max Drawdown 5-Year %

-83.2

Target Price

P/E

Forward P/E

PEG

P/S

1.22

P/B

0.94

P/Free Cash Flow

212.33

EPS

-2.28

Average EPS Est. Cur. Y

-0.13

EPS Next Y. (Est.)

0.26

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-29.29

Relative Volume

1.28

Return on Equity vs Sector %

-49.5

Return on Equity vs Industry %

-29.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ANIK” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANIK” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Anika Therapeutics Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 288

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide short-and long-term pain relief. The company's joint preservation and restoration product family comprises orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions. In addition, the company offers non-orthopedic products comprising HA-based products for Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier for use after abdominal-pelvic surgeries; and Hyalomatrix for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

stock quote shares ANIK – Anika Therapeutics Inc. Stock Price stock today

news today ANIK – Anika Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ANIK – Anika Therapeutics Inc. yahoo finance google finance

stock history ANIK – Anika Therapeutics Inc. invest stock market

stock prices ANIK premarket after hours

ticker ANIK fair value insiders trading

ANGO – Angiodynamic Inc

Float Short %

5.49

Margin Of Safety %

Put/Call OI Ratio

0.21

EPS Next Q Diff

0.17

EPS Last/This Y

0.5

EPS This/Next Y

0.2

Price

13.34

Target Price

19.33

Analyst Recom

Performance Q

27.29

Relative Volume

0.88

Beta

0.47

Ticker: ANGO

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-17	ANGO	11.9	0.22	0.00	3009
2025-11-18	ANGO	11.87	0.22	0.87	3019
2025-11-19	ANGO	11.9	0.22	8.57	3056
2025-11-20	ANGO	11.43	0.20	0.00	2997
2025-11-21	ANGO	11.94	0.20	0.47	2991
2025-11-24	ANGO	12.3	0.22	0.00	2061
2025-11-25	ANGO	12.4	0.21	0.00	2133
2025-11-26	ANGO	12.29	0.21	0.00	2143
2025-12-01	ANGO	12.96	0.21	0.21	2172
2025-12-02	ANGO	13.38	0.21	0.02	2180
2025-12-03	ANGO	13.48	0.21	0.56	2187
2025-12-04	ANGO	13.63	0.21	0.07	2186
2025-12-05	ANGO	13.47	0.21	0.00	2212
2025-12-08	ANGO	13.25	0.21	0.00	2216
2025-12-09	ANGO	13.14	0.21	0.00	2216
2025-12-10	ANGO	13.34	0.21	0.00	2216
2025-12-11	ANGO	13.44	0.21	0.24	2216
2025-12-12	ANGO	13.14	0.21	0.00	2231
2025-12-15	ANGO	13.36	0.21	0.21	2231
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-17	ANGO	11.90	-143.7	-	-0.32
2025-11-18	ANGO	11.88	-143.7	-	-0.32
2025-11-19	ANGO	11.90	-143.7	-	-0.32
2025-11-20	ANGO	11.42	-143.7	-	-0.32
2025-11-21	ANGO	11.94	-143.7	-	-0.32
2025-11-24	ANGO	12.29	-143.7	-	-0.32
2025-11-25	ANGO	12.40	-143.7	-	-0.32
2025-11-26	ANGO	12.30	-143.7	-	-0.32
2025-12-01	ANGO	12.98	-143.7	-	-0.32
2025-12-02	ANGO	13.37	-143.7	-	-0.32
2025-12-03	ANGO	13.49	-143.7	-	-0.32
2025-12-04	ANGO	13.62	-143.7	-	-0.32
2025-12-05	ANGO	13.47	-150.0	-	-0.33
2025-12-08	ANGO	13.26	-150.0	-	-0.33
2025-12-09	ANGO	13.16	-150.0	-	-0.33
2025-12-10	ANGO	13.16	-150.0	-	-0.33
2025-12-11	ANGO	13.44	-150.0	-	-0.33
2025-12-12	ANGO	13.14	-150.0	-	-0.33
2025-12-15	ANGO	13.34	-150.0	-	-0.33
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-17	ANGO	0.90	-2.93	6.43
2025-11-18	ANGO	0.90	-2.93	6.43
2025-11-19	ANGO	0.90	-2.93	6.43
2025-11-20	ANGO	0.90	-2.93	6.43
2025-11-21	ANGO	0.90	-2.93	6.43
2025-11-24	ANGO	0.90	3.42	6.43
2025-11-25	ANGO	0.90	3.42	6.43
2025-11-26	ANGO	0.90	3.42	5.60
2025-12-01	ANGO	0.90	3.46	5.60
2025-12-02	ANGO	0.90	3.46	5.60
2025-12-03	ANGO	0.90	3.46	5.60
2025-12-04	ANGO	0.90	3.46	5.60
2025-12-05	ANGO	0.90	3.46	5.60
2025-12-08	ANGO	0.90	3.77	5.60
2025-12-09	ANGO	0.90	3.77	5.60
2025-12-10	ANGO	0.90	3.77	5.49
2025-12-11	ANGO	0.90	3.77	5.49
2025-12-12	ANGO	0.90	3.77	5.49
2025-12-15	ANGO	0.90	3.77	5.49
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ANGO" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.26

Avg. EPS Est. Current Quarter

-0.1

Avg. EPS Est. Next Quarter

-0.09

Insider Transactions

0.9

Institutional Transactions

3.77

Beta

0.47

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

58.3

Max Drawdown 5-Year %

-83

Target Price

19.33

P/E

Forward P/E

PEG

P/S

1.83

P/B

3.09

P/Free Cash Flow

EPS

-0.78

Average EPS Est. Cur. Y

-0.33

EPS Next Y. (Est.)

-0.13

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-10.67

Relative Volume

0.88

Return on Equity vs Sector %

-44.9

Return on Equity vs Industry %

-27.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ANGO” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANGO” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

AngioDynamics, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 675

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

stock quote shares ANGO – Angiodynamic Inc Stock Price stock today

news today ANGO – Angiodynamic Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ANGO – Angiodynamic Inc yahoo finance google finance

stock history ANGO – Angiodynamic Inc invest stock market

stock prices ANGO premarket after hours

ticker ANGO fair value insiders trading

BLCO – Bausch + Lomb Corporation

Float Short %

8.58

Margin Of Safety %

Put/Call OI Ratio

0.35

EPS Next Q Diff

-0.09

EPS Last/This Y

EPS This/Next Y

0.25

Price

17.09

Target Price

17.23

Analyst Recom

2.31

Performance Q

14.7

Relative Volume

0.78

Beta

0.61

Ticker: BLCO

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-17	BLCO	15	0.33	0.01	12557
2025-11-18	BLCO	15.1	0.33	0.00	12603
2025-11-19	BLCO	14.61	0.33	0.24	12552
2025-11-20	BLCO	14.56	0.34	0.00	12655
2025-11-21	BLCO	15.08	0.34	0.00	12574
2025-11-24	BLCO	15.45	0.41	0.04	10313
2025-11-25	BLCO	15.89	0.40	0.05	10600
2025-11-26	BLCO	16.22	0.39	0.01	10762
2025-12-01	BLCO	16.58	0.39	0.00	10640
2025-12-02	BLCO	17.06	0.38	0.02	10732
2025-12-03	BLCO	16.94	0.38	0.00	10814
2025-12-04	BLCO	16.82	0.36	0.00	11145
2025-12-05	BLCO	16.82	0.36	0.00	11310
2025-12-08	BLCO	16.58	0.35	0.19	11464
2025-12-09	BLCO	16.46	0.35	0.00	11567
2025-12-10	BLCO	16.72	0.35	0.02	11659
2025-12-11	BLCO	17.28	0.36	0.13	11510
2025-12-12	BLCO	16.95	0.35	0.01	11767
2025-12-15	BLCO	17.09	0.35	0.00	11791
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-17	BLCO	14.99	42.9	-	0.52
2025-11-18	BLCO	15.10	43.5	-	0.53
2025-11-19	BLCO	14.62	43.5	-	0.53
2025-11-20	BLCO	14.56	43.5	-	0.53
2025-11-21	BLCO	15.09	43.5	-	0.53
2025-11-24	BLCO	15.46	43.5	-	0.53
2025-11-25	BLCO	15.89	43.5	-	0.53
2025-11-26	BLCO	16.22	43.5	-	0.53
2025-12-01	BLCO	16.58	43.5	-	0.53
2025-12-02	BLCO	17.05	43.5	-	0.53
2025-12-03	BLCO	16.96	43.5	-	0.53
2025-12-04	BLCO	16.81	43.5	-	0.53
2025-12-05	BLCO	16.82	43.5	-	0.53
2025-12-08	BLCO	16.56	43.5	-	0.53
2025-12-09	BLCO	16.46	43.5	-	0.53
2025-12-10	BLCO	16.72	43.5	-	0.53
2025-12-11	BLCO	17.28	43.5	-	0.53
2025-12-12	BLCO	16.98	43.5	-	0.53
2025-12-15	BLCO	17.09	43.5	-	0.53
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-17	BLCO	0.01	0.20	9.16
2025-11-18	BLCO	0.01	0.20	9.16
2025-11-19	BLCO	0.01	0.20	9.16
2025-11-20	BLCO	0.01	0.20	9.16
2025-11-21	BLCO	0.01	0.20	9.16
2025-11-24	BLCO	0.01	0.04	9.16
2025-11-25	BLCO	0.01	0.04	9.16
2025-11-26	BLCO	0.01	0.04	8.46
2025-12-01	BLCO	0.00	-0.02	8.46
2025-12-02	BLCO	0.00	-0.02	8.46
2025-12-03	BLCO	0.00	-0.02	8.46
2025-12-04	BLCO	0.00	-0.02	8.46
2025-12-05	BLCO	0.00	-0.02	8.46
2025-12-08	BLCO	0.00	-0.02	8.46
2025-12-09	BLCO	0.00	-0.02	8.46
2025-12-10	BLCO	0.00	-0.02	8.58
2025-12-11	BLCO	0.00	-0.02	8.58
2025-12-12	BLCO	0.00	-0.02	8.58
2025-12-15	BLCO	0.00	-0.02	8.58
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="BLCO" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

0.18

Avg. EPS Est. Current Quarter

0.36

Avg. EPS Est. Next Quarter

0.09

Insider Transactions

Institutional Transactions

-0.02

Beta

0.61

Average Sales Estimate Current Quarter

1383

Average Sales Estimate Next Quarter

1211

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

22.1

Max Drawdown 5-Year %

Target Price

17.23

P/E

Forward P/E

22.1

PEG

1.23

P/S

1.22

P/B

0.94

P/Free Cash Flow

EPS

-0.86

Average EPS Est. Cur. Y

0.53

EPS Next Y. (Est.)

0.78

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.13

Relative Volume

0.78

Return on Equity vs Sector %

-31.7

Return on Equity vs Industry %

-14.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”BLCO” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BLCO” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BLCO” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BLCO” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BLCO” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BLCO” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”BLCO” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Bausch + Lomb Corporation

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 13500

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provides optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

stock quote shares BLCO – Bausch + Lomb Corporation Stock Price stock today

news today BLCO – Bausch + Lomb Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch BLCO – Bausch + Lomb Corporation yahoo finance google finance

stock history BLCO – Bausch + Lomb Corporation invest stock market

stock prices BLCO premarket after hours

ticker BLCO fair value insiders trading

UTMD – Utah Medical Products, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: UTMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

ATRI – Atrion Corp.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ATRI

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y